Clinical factors and comorbidities affecting the cost of hospital-treated COPD

Sami Deniz,1 Aysun Şengül,2 Yusuf Aydemir,3 Jülide Çeldir Emre,4 Mustafa Hikmet Özhan5 1Clinics of Chest Diseases, Dr Suat Seren Chest Diseases and Thoracic Surgery Education and Research Hospital, İzmir, 2Clinics of Chest Diseases, Kocaeli Derince Research and...

Full description

Bibliographic Details
Main Authors: Deniz S, Şengül A, Aydemir Y, Çeldir Emre J, Özhan MH
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/clinical-factors-and-comorbidities-affecting-the-cost-of-hospital-trea-peer-reviewed-article-COPD
_version_ 1818180595527712768
author Deniz S
Şengül A
Aydemir Y
Çeldir Emre J
Özhan MH
author_facet Deniz S
Şengül A
Aydemir Y
Çeldir Emre J
Özhan MH
author_sort Deniz S
collection DOAJ
description Sami Deniz,1 Aysun Şengül,2 Yusuf Aydemir,3 Jülide Çeldir Emre,4 Mustafa Hikmet Özhan5 1Clinics of Chest Diseases, Dr Suat Seren Chest Diseases and Thoracic Surgery Education and Research Hospital, İzmir, 2Clinics of Chest Diseases, Kocaeli Derince Research and Education Hospital, Kocaeli, 3Department of Chest Diseases, Sakarya University Faculty of Medicine, Sakarya, 4Clinics of Chest Diseases, Turgutlu State Hospital, Manisa, 5Department of Chest Diseases, Faculty of Medicine, Ege University İzmir, Turkey Purpose: We aimed to assess the effects of comorbidities on COPD costs and to investigate the relationship between comorbidities and clinical variables.Patients and methods: All patients hospitalized with a diagnosis of COPD exacerbation between January 1, 2014, and December 31, 2014, at all state hospitals of Aydin province, a city located in the western part of Turkey, were included in this study. The costs examined in the study pertained to medications, laboratory tests, hospital stays, and other treatment-related factors, such as consumption of materials, doctor visits, and consultation fees.Results: A total of 3,095 patients with 5,237 exacerbations (mean age, 71.9±10.5 years; 2,434 males and 661 females) were evaluated. For 880 of the patients (28.9%), or 3,852 of the exacerbations (73.1%), at least one comorbid disease was recorded. The mean cost of each exacerbation was $808.5±1,586, including $325.1±879.9 (40.7%) for hospital stays, $223.1±1,300.9 (27.6%) for medications, $46.3±49.6 (0.9%) for laboratory expenditures, and $214±1,068 (26.5%) for other treatment-related factors, such as consumption of materials, doctor visits, and consultation fees. The cost of each exacerbation was $1,014.9 in patients with at least one comorbidity, whereas it was $233.6 in patients without comorbidity (P<0.001). Age >65 years, female gender, hospitalization in an intensive care unit, invasive or noninvasive mechanical ventilation, and a long duration of hospitalization were all found to be significant factors in increasing total costs during the exacerbations requiring hospitalization (P<0.05 for all).Conclusion: Comorbidities have an important role in the total costs of acute exacerbations of COPD. Strategies for the prevention, diagnosis, and effective management of comorbidities would decrease the overall financial burden associated with acute exacerbations of COPD. Keywords: COPD, exacerbation, cost, comorbidity, morbidity, intensive care unit
first_indexed 2024-12-11T21:22:16Z
format Article
id doaj.art-0fd7c220bb66486c826b565f7bbc2764
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-11T21:22:16Z
publishDate 2016-12-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-0fd7c220bb66486c826b565f7bbc27642022-12-22T00:50:26ZengDove Medical PressInternational Journal of COPD1178-20052016-12-01Volume 113023303030304Clinical factors and comorbidities affecting the cost of hospital-treated COPDDeniz SŞengül AAydemir YÇeldir Emre JÖzhan MHSami Deniz,1 Aysun Şengül,2 Yusuf Aydemir,3 Jülide Çeldir Emre,4 Mustafa Hikmet Özhan5 1Clinics of Chest Diseases, Dr Suat Seren Chest Diseases and Thoracic Surgery Education and Research Hospital, İzmir, 2Clinics of Chest Diseases, Kocaeli Derince Research and Education Hospital, Kocaeli, 3Department of Chest Diseases, Sakarya University Faculty of Medicine, Sakarya, 4Clinics of Chest Diseases, Turgutlu State Hospital, Manisa, 5Department of Chest Diseases, Faculty of Medicine, Ege University İzmir, Turkey Purpose: We aimed to assess the effects of comorbidities on COPD costs and to investigate the relationship between comorbidities and clinical variables.Patients and methods: All patients hospitalized with a diagnosis of COPD exacerbation between January 1, 2014, and December 31, 2014, at all state hospitals of Aydin province, a city located in the western part of Turkey, were included in this study. The costs examined in the study pertained to medications, laboratory tests, hospital stays, and other treatment-related factors, such as consumption of materials, doctor visits, and consultation fees.Results: A total of 3,095 patients with 5,237 exacerbations (mean age, 71.9±10.5 years; 2,434 males and 661 females) were evaluated. For 880 of the patients (28.9%), or 3,852 of the exacerbations (73.1%), at least one comorbid disease was recorded. The mean cost of each exacerbation was $808.5±1,586, including $325.1±879.9 (40.7%) for hospital stays, $223.1±1,300.9 (27.6%) for medications, $46.3±49.6 (0.9%) for laboratory expenditures, and $214±1,068 (26.5%) for other treatment-related factors, such as consumption of materials, doctor visits, and consultation fees. The cost of each exacerbation was $1,014.9 in patients with at least one comorbidity, whereas it was $233.6 in patients without comorbidity (P<0.001). Age >65 years, female gender, hospitalization in an intensive care unit, invasive or noninvasive mechanical ventilation, and a long duration of hospitalization were all found to be significant factors in increasing total costs during the exacerbations requiring hospitalization (P<0.05 for all).Conclusion: Comorbidities have an important role in the total costs of acute exacerbations of COPD. Strategies for the prevention, diagnosis, and effective management of comorbidities would decrease the overall financial burden associated with acute exacerbations of COPD. Keywords: COPD, exacerbation, cost, comorbidity, morbidity, intensive care unithttps://www.dovepress.com/clinical-factors-and-comorbidities-affecting-the-cost-of-hospital-trea-peer-reviewed-article-COPDCOPDexacerbationcostcomorbiditymorbidityintensive care unit
spellingShingle Deniz S
Şengül A
Aydemir Y
Çeldir Emre J
Özhan MH
Clinical factors and comorbidities affecting the cost of hospital-treated COPD
International Journal of COPD
COPD
exacerbation
cost
comorbidity
morbidity
intensive care unit
title Clinical factors and comorbidities affecting the cost of hospital-treated COPD
title_full Clinical factors and comorbidities affecting the cost of hospital-treated COPD
title_fullStr Clinical factors and comorbidities affecting the cost of hospital-treated COPD
title_full_unstemmed Clinical factors and comorbidities affecting the cost of hospital-treated COPD
title_short Clinical factors and comorbidities affecting the cost of hospital-treated COPD
title_sort clinical factors and comorbidities affecting the cost of hospital treated copd
topic COPD
exacerbation
cost
comorbidity
morbidity
intensive care unit
url https://www.dovepress.com/clinical-factors-and-comorbidities-affecting-the-cost-of-hospital-trea-peer-reviewed-article-COPD
work_keys_str_mv AT denizs clinicalfactorsandcomorbiditiesaffectingthecostofhospitaltreatedcopd
AT sengula clinicalfactorsandcomorbiditiesaffectingthecostofhospitaltreatedcopd
AT aydemiry clinicalfactorsandcomorbiditiesaffectingthecostofhospitaltreatedcopd
AT celdiremrej clinicalfactorsandcomorbiditiesaffectingthecostofhospitaltreatedcopd
AT ozhanmh clinicalfactorsandcomorbiditiesaffectingthecostofhospitaltreatedcopd